- Home
- CRDF vs OPFI Comparison
CRDF vs OPFI Comparison
Compare CRDF & OPFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRDF
- OPFI
- Stock Information
- Founded
- CRDF 1999
- OPFI 2009
- Country
- CRDF United States
- OPFI United States
- Employees
- CRDF N/A
- OPFI N/A
- Industry
- CRDF Biotechnology: Biological Products (No Diagnostic Substances)
- OPFI Finance: Consumer Services
- Sector
- CRDF Health Care
- OPFI Finance
- Exchange
- CRDF Nasdaq
- OPFI Nasdaq
- Market Cap
- CRDF 196.2M
- OPFI 205.2M
- IPO Year
- CRDF N/A
- OPFI N/A
- Fundamental
- Price
- CRDF $2.63
- OPFI $11.60
- Analyst Decision
- CRDF Strong Buy
- OPFI Buy
- Analyst Count
- CRDF 4
- OPFI 2
- Target Price
- CRDF $12.00
- OPFI $11.75
- AVG Volume (30 Days)
- CRDF 1.1M
- OPFI 800.9K
- Earning Date
- CRDF 05-20-2025
- OPFI 05-07-2025
- Dividend Yield
- CRDF N/A
- OPFI 2.15%
- EPS Growth
- CRDF N/A
- OPFI N/A
- EPS
- CRDF N/A
- OPFI 0.36
- Revenue
- CRDF $683,000.00
- OPFI $276,770,000.00
- Revenue This Year
- CRDF N/A
- OPFI $112.50
- Revenue Next Year
- CRDF N/A
- OPFI $7.84
- P/E Ratio
- CRDF N/A
- OPFI $32.25
- Revenue Growth
- CRDF 39.96
- OPFI 22.23
- 52 Week Low
- CRDF $2.01
- OPFI $2.82
- 52 Week High
- CRDF $5.64
- OPFI $17.73
- Technical
- Relative Strength Index (RSI)
- CRDF 41.22
- OPFI 71.65
- Support Level
- CRDF $2.42
- OPFI $9.43
- Resistance Level
- CRDF $2.87
- OPFI $10.07
- Average True Range (ATR)
- CRDF 0.18
- OPFI 0.50
- MACD
- CRDF 0.01
- OPFI 0.30
- Stochastic Oscillator
- CRDF 24.42
- OPFI 84.41
About CRDF Cardiff Oncology Inc.
Cardiff Oncology Inc is a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical programs in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC"). Geographically, the company only operates in the United States.
About OPFI OppFi Inc.
OppFi Inc is a tech-enabled, mission-driven specialty finance platform that broadens the reach of community banks to extend credit access to everyday Americans. It recognizes revenue through finance charges on installment and SalaryTap contracts based on the interest method.